Related Experiment Videos
[The intraurethral catheter. A 3-year experience]
1Department of Urology, Meir General Hospital, Kfar Saba, Israël.
Journal D'Urologie
|January 1, 1993
Summary
Prostatic stents (intraurethral stents) effectively treated benign prostatic hyperplasia in 80.8% of patients, resolving chronic urinary retention and severe obstructive symptoms. This offers a viable alternative for high-risk surgical candidates or temporary catheter replacement.
Area of Science:
- Urology
- Medical Devices
Context:
- Benign prostatic hyperplasia (BPH) affects numerous men, often leading to chronic urinary retention or severe obstructive symptoms.
- Current management includes surgery or indwelling catheters, which carry risks and limitations.
Purpose:
- To evaluate the efficacy and safety of intraurethral stents (IUCs) in managing benign prostatic hyperplasia.
Summary:
- 130 intraurethral stents were inserted in 94 patients with BPH.
- 80.8% of stent insertions were successful, with stents remaining in place for 1 to 19 months.
- All patients maintained continence, with significant symptom improvement.
Impact:
- Intraurethral stents demonstrate potential as a less invasive alternative to surgery for high-risk BPH patients.
- Stents can serve as a temporary solution, replacing indwelling catheters until definitive surgical treatment.